Share Price and Basic Stock Data
Last Updated: January 2, 2026, 7:31 pm
| PEG Ratio | -28.26 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Hindcon Chemicals Ltd operates in the chemicals sector, specifically categorized under ‘Chemicals – Others’. The company’s stock price stood at ₹27.2, with a market capitalization of ₹139 Cr. Hindcon Chemicals reported a total revenue of ₹85.59 Cr. for the fiscal year ending March 2023, reflecting a significant increase compared to ₹66.62 Cr. in the previous fiscal year. However, the company faced a revenue decline in FY 2024, with sales reported at ₹64.51 Cr. This downward trend continued into FY 2025, where sales were recorded at ₹56.59 Cr. The company’s quarterly sales have shown volatility, with the latest reported quarter (Sep 2023) achieving ₹19.46 Cr., down from ₹26.64 Cr. in Dec 2022. Such fluctuations highlight the challenges in maintaining consistent revenue streams in a competitive market environment.
Profitability and Efficiency Metrics
Hindcon Chemicals reported a net profit of ₹4.36 Cr. for the fiscal year ending March 2023, a slight increase from ₹4.26 Cr. in FY 2022. However, net profit for FY 2025 is expected to decline to ₹3.83 Cr. This trajectory poses concerns regarding profitability sustainability. The company’s operating profit margin (OPM) stood at 6.04% for FY 2023, reflecting a decrease from 7.49% in FY 2022, indicating tighter margins amidst rising operational costs. Hindcon’s return on equity (ROE) was reported at 7.27%, while the return on capital employed (ROCE) stood at 9.97%. These figures suggest that, while the company is generating a return on its equity and capital, the levels are not particularly high compared to industry averages, potentially limiting investor appeal.
Balance Sheet Strength and Financial Ratios
The balance sheet of Hindcon Chemicals reveals a solid financial foundation with total reserves amounting to ₹48.38 Cr. and borrowings of only ₹6.18 Cr., resulting in a low debt-to-equity ratio of 0.01. This indicates minimal reliance on external financing, which is a strength in maintaining financial stability. Additionally, the interest coverage ratio (ICR) was notably high at 79.32x, showcasing strong capability to cover interest expenses. The current ratio stood at 5.36, indicating robust liquidity, while the quick ratio was recorded at 5.13, both well above the typical sector thresholds. However, the company’s price-to-book value (P/BV) ratio of 2.28x suggests that the stock may be trading at a premium, warranting caution for potential investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Hindcon Chemicals indicates a strong promoter presence, with promoters holding 68.71% of the total shares as of Sep 2025. This level of ownership can instill confidence among investors regarding management commitment. The public shareholding stood at 31.29%, with foreign institutional investors (FIIs) holding a negligible 0.00%, indicating limited external institutional interest. The number of shareholders has shown fluctuations, rising to 29,663 by Sep 2025, which may suggest increasing retail investor interest. However, the absence of FIIs could be a concern, as institutional backing often enhances stock credibility. The overall investor sentiment appears cautiously optimistic, given the strong promoter stake and rising shareholder numbers.
Outlook, Risks, and Final Insight
Looking ahead, Hindcon Chemicals faces both opportunities and risks. The company’s strong balance sheet and low debt levels provide a buffer against economic uncertainties. However, the declining revenue trend and profitability metrics raise concerns about future growth prospects. Key risks include reliance on a volatile chemicals market and potential operational challenges that may impact margins further. If Hindcon can stabilize its revenue and improve profitability, it may enhance its appeal to investors. Conversely, continued decline in sales and profitability could lead to reduced investor confidence, affecting share prices. A focused strategy on operational efficiency and market expansion could mitigate these risks, positioning the company favorably in the competitive landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Diamines & Chemicals Ltd | 258 Cr. | 264 | 514/250 | 158 | 0.38 % | 3.33 % | 1.78 % | 10.0 | |
| Deco-Mica Ltd | 26.8 Cr. | 63.7 | 90.0/56.0 | 14.6 | 64.2 | 0.00 % | 11.8 % | 7.51 % | 10.0 |
| Andhra Sugars Ltd | 1,030 Cr. | 76.0 | 97.8/64.9 | 12.9 | 121 | 1.05 % | 3.54 % | 2.51 % | 2.00 |
| Tamil Nadu Petro Products Ltd | 951 Cr. | 106 | 130/63.6 | 9.50 | 109 | 1.14 % | 6.97 % | 5.10 % | 10.0 |
| SRF Ltd | 90,691 Cr. | 3,060 | 3,325/2,260 | 56.1 | 447 | 0.24 % | 12.3 % | 10.4 % | 10.0 |
| Industry Average | 14,582.22 Cr | 1,169.39 | 33.11 | 204.33 | 0.41% | 10.57% | 8.89% | 7.60 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.64 | 26.64 | 19.25 | 17.27 | 19.46 | 13.44 | 14.34 | 12.91 | 12.96 | 15.27 | 15.44 | 14.88 | 15.32 |
| Expenses | 18.19 | 24.86 | 17.59 | 14.18 | 18.44 | 12.25 | 12.55 | 11.18 | 12.71 | 14.06 | 14.40 | 13.18 | 14.57 |
| Operating Profit | 0.45 | 1.78 | 1.66 | 3.09 | 1.02 | 1.19 | 1.79 | 1.73 | 0.25 | 1.21 | 1.04 | 1.70 | 0.75 |
| OPM % | 2.41% | 6.68% | 8.62% | 17.89% | 5.24% | 8.85% | 12.48% | 13.40% | 1.93% | 7.92% | 6.74% | 11.42% | 4.90% |
| Other Income | 0.42 | 0.27 | 0.27 | 0.41 | 0.31 | 0.29 | 0.67 | 0.35 | 0.74 | 0.86 | -0.05 | 0.43 | 0.55 |
| Interest | 0.01 | 0.02 | 0.01 | 0.01 | 0.03 | 0.01 | 0.02 | 0.00 | 0.02 | 0.01 | 0.05 | 0.04 | 0.10 |
| Depreciation | 0.07 | 0.07 | 0.08 | 0.06 | 0.07 | 0.08 | 0.14 | 0.19 | 0.20 | 0.20 | 0.23 | 0.21 | 0.23 |
| Profit before tax | 0.79 | 1.96 | 1.84 | 3.43 | 1.23 | 1.39 | 2.30 | 1.89 | 0.77 | 1.86 | 0.71 | 1.88 | 0.97 |
| Tax % | 31.65% | 27.55% | 26.63% | 25.66% | 30.08% | 27.34% | 21.74% | 30.16% | 23.38% | 25.81% | 22.54% | 28.19% | 25.77% |
| Net Profit | 0.54 | 1.41 | 1.36 | 2.55 | 0.88 | 1.01 | 1.80 | 1.31 | 0.58 | 1.37 | 0.55 | 1.35 | 0.72 |
| EPS in Rs | 0.11 | 0.27 | 0.26 | 0.49 | 0.17 | 0.20 | 0.35 | 0.25 | 0.11 | 0.27 | 0.11 | 0.26 | 0.14 |
Last Updated: January 1, 2026, 11:16 am
Below is a detailed analysis of the quarterly data for Hindcon Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 15.32 Cr.. The value appears strong and on an upward trend. It has increased from 14.88 Cr. (Jun 2025) to 15.32 Cr., marking an increase of 0.44 Cr..
- For Expenses, as of Sep 2025, the value is 14.57 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.18 Cr. (Jun 2025) to 14.57 Cr., marking an increase of 1.39 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.75 Cr.. The value appears to be declining and may need further review. It has decreased from 1.70 Cr. (Jun 2025) to 0.75 Cr., marking a decrease of 0.95 Cr..
- For OPM %, as of Sep 2025, the value is 4.90%. The value appears to be declining and may need further review. It has decreased from 11.42% (Jun 2025) to 4.90%, marking a decrease of 6.52%.
- For Other Income, as of Sep 2025, the value is 0.55 Cr.. The value appears strong and on an upward trend. It has increased from 0.43 Cr. (Jun 2025) to 0.55 Cr., marking an increase of 0.12 Cr..
- For Interest, as of Sep 2025, the value is 0.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.04 Cr. (Jun 2025) to 0.10 Cr., marking an increase of 0.06 Cr..
- For Depreciation, as of Sep 2025, the value is 0.23 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.21 Cr. (Jun 2025) to 0.23 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.97 Cr.. The value appears to be declining and may need further review. It has decreased from 1.88 Cr. (Jun 2025) to 0.97 Cr., marking a decrease of 0.91 Cr..
- For Tax %, as of Sep 2025, the value is 25.77%. The value appears to be improving (decreasing) as expected. It has decreased from 28.19% (Jun 2025) to 25.77%, marking a decrease of 2.42%.
- For Net Profit, as of Sep 2025, the value is 0.72 Cr.. The value appears to be declining and may need further review. It has decreased from 1.35 Cr. (Jun 2025) to 0.72 Cr., marking a decrease of 0.63 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.14. The value appears to be declining and may need further review. It has decreased from 0.26 (Jun 2025) to 0.14, marking a decrease of 0.12.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:15 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 32.83 | 32.34 | 33.81 | 35.28 | 44.40 | 44.07 | 44.27 | 66.62 | 85.59 | 64.51 | 56.59 | 60.91 |
| Expenses | 33.30 | 30.24 | 30.20 | 30.49 | 40.65 | 40.55 | 39.71 | 61.63 | 80.42 | 57.41 | 52.35 | 56.21 |
| Operating Profit | -0.47 | 2.10 | 3.61 | 4.79 | 3.75 | 3.52 | 4.56 | 4.99 | 5.17 | 7.10 | 4.24 | 4.70 |
| OPM % | -1.43% | 6.49% | 10.68% | 13.58% | 8.45% | 7.99% | 10.30% | 7.49% | 6.04% | 11.01% | 7.49% | 7.72% |
| Other Income | 2.03 | 0.09 | 0.35 | 0.98 | 0.57 | 1.00 | 2.15 | 1.37 | 1.19 | 1.68 | 1.89 | 1.79 |
| Interest | 0.79 | 0.68 | 0.67 | 0.52 | 0.23 | 0.09 | 0.08 | 0.02 | 0.05 | 0.08 | 0.08 | 0.20 |
| Depreciation | 0.27 | 0.21 | 0.18 | 0.14 | 0.13 | 0.14 | 0.18 | 0.25 | 0.29 | 0.35 | 0.82 | 0.87 |
| Profit before tax | 0.50 | 1.30 | 3.11 | 5.11 | 3.96 | 4.29 | 6.45 | 6.09 | 6.02 | 8.35 | 5.23 | 5.42 |
| Tax % | 32.00% | 34.62% | 32.80% | 22.31% | 28.03% | 33.33% | 25.89% | 30.05% | 27.74% | 25.39% | 26.58% | |
| Net Profit | 0.34 | 0.85 | 2.09 | 3.98 | 2.82 | 2.84 | 4.77 | 4.26 | 4.36 | 6.23 | 3.83 | 3.99 |
| EPS in Rs | 0.45 | 1.12 | 2.76 | 0.78 | 0.55 | 0.55 | 0.92 | 0.83 | 0.84 | 1.21 | 0.74 | 0.78 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 16.32% | 24.31% | 24.32% | 30.83% | 0.00% | 12.41% | 60.55% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 150.00% | 145.88% | 90.43% | -29.15% | 0.71% | 67.96% | -10.69% | 2.35% | 42.89% | -38.52% |
| Change in YoY Net Profit Growth (%) | 0.00% | -4.12% | -55.45% | -119.58% | 29.85% | 67.25% | -78.65% | 13.04% | 40.54% | -81.41% |
Hindcon Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 5% |
| 3 Years: | -5% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 6% |
| 3 Years: | -3% |
| TTM: | -23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 57% |
| 3 Years: | 30% |
| 1 Year: | -40% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 11% |
| 3 Years: | 10% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 6:10 am
Balance Sheet
Last Updated: December 4, 2025, 1:22 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.76 | 0.76 | 0.85 | 10.24 | 7.67 | 7.67 | 7.67 | 7.67 | 7.67 | 7.67 | 7.67 | 7.67 |
| Reserves | 10.69 | 11.50 | 14.23 | 15.47 | 22.42 | 24.67 | 27.78 | 31.47 | 34.68 | 42.28 | 46.35 | 48.38 |
| Borrowings | 8.92 | 5.28 | 5.02 | 0.82 | 0.18 | 0.30 | 0.99 | 1.24 | 0.98 | 0.00 | 0.77 | 6.18 |
| Other Liabilities | 4.43 | 6.30 | 5.94 | 6.60 | 5.95 | 6.73 | 6.78 | 12.23 | 10.31 | 9.62 | 8.79 | 10.15 |
| Total Liabilities | 24.80 | 23.84 | 26.04 | 33.13 | 36.22 | 39.37 | 43.22 | 52.61 | 53.64 | 59.57 | 63.58 | 72.38 |
| Fixed Assets | 0.93 | 0.92 | 1.11 | 1.08 | 1.00 | 1.13 | 1.41 | 1.72 | 2.57 | 6.25 | 7.11 | 7.78 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.39 | 0.00 | 0.00 | 0.00 |
| Investments | 0.28 | 0.66 | 0.81 | 3.24 | 4.32 | 4.47 | 2.79 | 3.21 | 2.19 | 4.66 | 4.76 | 4.78 |
| Other Assets | 23.59 | 22.26 | 24.12 | 28.81 | 30.90 | 33.77 | 39.02 | 47.68 | 48.49 | 48.66 | 51.71 | 59.82 |
| Total Assets | 24.80 | 23.84 | 26.04 | 33.13 | 36.22 | 39.37 | 43.22 | 52.61 | 53.64 | 59.57 | 63.58 | 72.38 |
Below is a detailed analysis of the balance sheet data for Hindcon Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 7.67 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.67 Cr..
- For Reserves, as of Sep 2025, the value is 48.38 Cr.. The value appears strong and on an upward trend. It has increased from 46.35 Cr. (Mar 2025) to 48.38 Cr., marking an increase of 2.03 Cr..
- For Borrowings, as of Sep 2025, the value is 6.18 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.77 Cr. (Mar 2025) to 6.18 Cr., marking an increase of 5.41 Cr..
- For Other Liabilities, as of Sep 2025, the value is 10.15 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.79 Cr. (Mar 2025) to 10.15 Cr., marking an increase of 1.36 Cr..
- For Total Liabilities, as of Sep 2025, the value is 72.38 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 63.58 Cr. (Mar 2025) to 72.38 Cr., marking an increase of 8.80 Cr..
- For Fixed Assets, as of Sep 2025, the value is 7.78 Cr.. The value appears strong and on an upward trend. It has increased from 7.11 Cr. (Mar 2025) to 7.78 Cr., marking an increase of 0.67 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 4.78 Cr.. The value appears strong and on an upward trend. It has increased from 4.76 Cr. (Mar 2025) to 4.78 Cr., marking an increase of 0.02 Cr..
- For Other Assets, as of Sep 2025, the value is 59.82 Cr.. The value appears strong and on an upward trend. It has increased from 51.71 Cr. (Mar 2025) to 59.82 Cr., marking an increase of 8.11 Cr..
- For Total Assets, as of Sep 2025, the value is 72.38 Cr.. The value appears strong and on an upward trend. It has increased from 63.58 Cr. (Mar 2025) to 72.38 Cr., marking an increase of 8.80 Cr..
Notably, the Reserves (48.38 Cr.) exceed the Borrowings (6.18 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -9.39 | -3.18 | -1.41 | 3.97 | 3.57 | 3.22 | 3.57 | 3.75 | 4.19 | 7.10 | 3.47 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 199.90 | 204.51 | 199.50 | 189.43 | 159.56 | 164.24 | 158.38 | 144.42 | 111.65 | 125.83 | 139.38 |
| Inventory Days | 17.87 | 18.30 | 13.08 | 43.62 | 28.94 | 22.98 | 21.77 | 24.26 | 17.35 | 12.03 | 18.18 |
| Days Payable | 41.21 | 60.55 | 50.92 | 55.52 | 39.08 | 54.34 | 50.63 | 53.69 | 38.78 | 42.55 | 49.05 |
| Cash Conversion Cycle | 176.57 | 162.27 | 161.66 | 177.53 | 149.42 | 132.88 | 129.53 | 115.00 | 90.22 | 95.32 | 108.51 |
| Working Capital Days | 193.45 | 169.41 | 128.68 | 169.67 | 189.98 | 198.19 | 159.46 | 152.75 | 114.63 | 128.27 | 148.15 |
| ROCE % | 10.43% | 19.92% | 21.20% | 14.70% | 13.98% | 18.85% | 15.69% | 14.34% | 17.87% | 9.97% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.00 | 1.62 | 5.68 | 5.56 | 5.89 |
| Diluted EPS (Rs.) | 1.00 | 1.62 | 5.68 | 5.56 | 5.89 |
| Cash EPS (Rs.) | 1.21 | 1.72 | 6.05 | 5.89 | 6.19 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 14.08 | 13.18 | 55.83 | 51.61 | 47.51 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 14.08 | 13.18 | 55.83 | 51.61 | 47.51 |
| Revenue From Operations / Share (Rs.) | 14.75 | 16.82 | 111.57 | 86.83 | 57.85 |
| PBDIT / Share (Rs.) | 1.60 | 2.29 | 8.29 | 8.30 | 8.59 |
| PBIT / Share (Rs.) | 1.38 | 2.20 | 7.92 | 7.97 | 8.34 |
| PBT / Share (Rs.) | 1.36 | 2.18 | 7.85 | 7.94 | 8.32 |
| Net Profit / Share (Rs.) | 0.99 | 1.62 | 5.68 | 5.56 | 5.95 |
| NP After MI And SOA / Share (Rs.) | 0.99 | 1.61 | 5.63 | 5.51 | 5.89 |
| PBDIT Margin (%) | 10.82 | 13.61 | 7.43 | 9.55 | 14.84 |
| PBIT Margin (%) | 9.37 | 13.06 | 7.09 | 9.17 | 14.42 |
| PBT Margin (%) | 9.23 | 12.94 | 7.03 | 9.14 | 14.39 |
| Net Profit Margin (%) | 6.76 | 9.66 | 5.08 | 6.39 | 10.28 |
| NP After MI And SOA Margin (%) | 6.71 | 9.58 | 5.04 | 6.35 | 10.18 |
| Return on Networth / Equity (%) | 7.03 | 12.37 | 10.19 | 10.80 | 12.50 |
| Return on Capital Employeed (%) | 9.57 | 16.57 | 14.06 | 15.42 | 17.42 |
| Return On Assets (%) | 5.95 | 10.37 | 8.05 | 8.04 | 10.15 |
| Total Debt / Equity (X) | 0.01 | 0.00 | 0.02 | 0.03 | 0.02 |
| Asset Turnover Ratio (%) | 0.91 | 1.14 | 1.61 | 1.35 | 1.09 |
| Current Ratio (X) | 5.36 | 4.95 | 4.56 | 3.56 | 4.83 |
| Quick Ratio (X) | 5.13 | 4.77 | 4.24 | 3.29 | 4.57 |
| Inventory Turnover Ratio (X) | 32.11 | 13.20 | 14.54 | 11.99 | 11.21 |
| Dividend Payout Ratio (NP) (%) | 10.19 | 6.27 | 12.43 | 45.54 | 15.26 |
| Dividend Payout Ratio (CP) (%) | 8.38 | 5.93 | 11.65 | 42.97 | 14.66 |
| Earning Retention Ratio (%) | 89.81 | 93.73 | 87.57 | 54.46 | 84.74 |
| Cash Earning Retention Ratio (%) | 91.62 | 94.07 | 88.35 | 57.03 | 85.34 |
| Interest Coverage Ratio (X) | 79.32 | 116.14 | 126.44 | 284.21 | 447.20 |
| Interest Coverage Ratio (Post Tax) (X) | 50.61 | 83.43 | 87.60 | 191.32 | 310.80 |
| Enterprise Value (Cr.) | 110.57 | 188.47 | 51.83 | 49.65 | 9.63 |
| EV / Net Operating Revenue (X) | 1.95 | 2.92 | 0.60 | 0.74 | 0.21 |
| EV / EBITDA (X) | 18.06 | 21.47 | 8.15 | 7.80 | 1.46 |
| MarketCap / Net Operating Revenue (X) | 2.18 | 3.10 | 0.70 | 0.80 | 0.42 |
| Retention Ratios (%) | 89.80 | 93.72 | 87.56 | 54.45 | 84.73 |
| Price / BV (X) | 2.28 | 4.00 | 1.43 | 1.36 | 0.51 |
| Price / Net Operating Revenue (X) | 2.18 | 3.10 | 0.70 | 0.80 | 0.42 |
| EarningsYield | 0.03 | 0.03 | 0.07 | 0.07 | 0.24 |
After reviewing the key financial ratios for Hindcon Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.00. This value is below the healthy minimum of 5. It has decreased from 1.62 (Mar 24) to 1.00, marking a decrease of 0.62.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.00. This value is below the healthy minimum of 5. It has decreased from 1.62 (Mar 24) to 1.00, marking a decrease of 0.62.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.21. This value is below the healthy minimum of 3. It has decreased from 1.72 (Mar 24) to 1.21, marking a decrease of 0.51.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.08. It has increased from 13.18 (Mar 24) to 14.08, marking an increase of 0.90.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.08. It has increased from 13.18 (Mar 24) to 14.08, marking an increase of 0.90.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 14.75. It has decreased from 16.82 (Mar 24) to 14.75, marking a decrease of 2.07.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.60. This value is below the healthy minimum of 2. It has decreased from 2.29 (Mar 24) to 1.60, marking a decrease of 0.69.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.38. This value is within the healthy range. It has decreased from 2.20 (Mar 24) to 1.38, marking a decrease of 0.82.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.36. This value is within the healthy range. It has decreased from 2.18 (Mar 24) to 1.36, marking a decrease of 0.82.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 2. It has decreased from 1.62 (Mar 24) to 0.99, marking a decrease of 0.63.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 2. It has decreased from 1.61 (Mar 24) to 0.99, marking a decrease of 0.62.
- For PBDIT Margin (%), as of Mar 25, the value is 10.82. This value is within the healthy range. It has decreased from 13.61 (Mar 24) to 10.82, marking a decrease of 2.79.
- For PBIT Margin (%), as of Mar 25, the value is 9.37. This value is below the healthy minimum of 10. It has decreased from 13.06 (Mar 24) to 9.37, marking a decrease of 3.69.
- For PBT Margin (%), as of Mar 25, the value is 9.23. This value is below the healthy minimum of 10. It has decreased from 12.94 (Mar 24) to 9.23, marking a decrease of 3.71.
- For Net Profit Margin (%), as of Mar 25, the value is 6.76. This value is within the healthy range. It has decreased from 9.66 (Mar 24) to 6.76, marking a decrease of 2.90.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.71. This value is below the healthy minimum of 8. It has decreased from 9.58 (Mar 24) to 6.71, marking a decrease of 2.87.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.03. This value is below the healthy minimum of 15. It has decreased from 12.37 (Mar 24) to 7.03, marking a decrease of 5.34.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.57. This value is below the healthy minimum of 10. It has decreased from 16.57 (Mar 24) to 9.57, marking a decrease of 7.00.
- For Return On Assets (%), as of Mar 25, the value is 5.95. This value is within the healthy range. It has decreased from 10.37 (Mar 24) to 5.95, marking a decrease of 4.42.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.91. It has decreased from 1.14 (Mar 24) to 0.91, marking a decrease of 0.23.
- For Current Ratio (X), as of Mar 25, the value is 5.36. This value exceeds the healthy maximum of 3. It has increased from 4.95 (Mar 24) to 5.36, marking an increase of 0.41.
- For Quick Ratio (X), as of Mar 25, the value is 5.13. This value exceeds the healthy maximum of 2. It has increased from 4.77 (Mar 24) to 5.13, marking an increase of 0.36.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 32.11. This value exceeds the healthy maximum of 8. It has increased from 13.20 (Mar 24) to 32.11, marking an increase of 18.91.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 10.19. This value is below the healthy minimum of 20. It has increased from 6.27 (Mar 24) to 10.19, marking an increase of 3.92.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.38. This value is below the healthy minimum of 20. It has increased from 5.93 (Mar 24) to 8.38, marking an increase of 2.45.
- For Earning Retention Ratio (%), as of Mar 25, the value is 89.81. This value exceeds the healthy maximum of 70. It has decreased from 93.73 (Mar 24) to 89.81, marking a decrease of 3.92.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.62. This value exceeds the healthy maximum of 70. It has decreased from 94.07 (Mar 24) to 91.62, marking a decrease of 2.45.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 79.32. This value is within the healthy range. It has decreased from 116.14 (Mar 24) to 79.32, marking a decrease of 36.82.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 50.61. This value is within the healthy range. It has decreased from 83.43 (Mar 24) to 50.61, marking a decrease of 32.82.
- For Enterprise Value (Cr.), as of Mar 25, the value is 110.57. It has decreased from 188.47 (Mar 24) to 110.57, marking a decrease of 77.90.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has decreased from 2.92 (Mar 24) to 1.95, marking a decrease of 0.97.
- For EV / EBITDA (X), as of Mar 25, the value is 18.06. This value exceeds the healthy maximum of 15. It has decreased from 21.47 (Mar 24) to 18.06, marking a decrease of 3.41.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has decreased from 3.10 (Mar 24) to 2.18, marking a decrease of 0.92.
- For Retention Ratios (%), as of Mar 25, the value is 89.80. This value exceeds the healthy maximum of 70. It has decreased from 93.72 (Mar 24) to 89.80, marking a decrease of 3.92.
- For Price / BV (X), as of Mar 25, the value is 2.28. This value is within the healthy range. It has decreased from 4.00 (Mar 24) to 2.28, marking a decrease of 1.72.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has decreased from 3.10 (Mar 24) to 2.18, marking a decrease of 0.92.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindcon Chemicals Ltd:
- Net Profit Margin: 6.76%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.57% (Industry Average ROCE: 10.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.03% (Industry Average ROE: 8.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 50.61
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 5.13
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 34.9 (Industry average Stock P/E: 33.11)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.76%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Others | No: 62/B, Braunfeld Row, Kolkata West Bengal 700027 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sanjay Goenka | Chairman & Managing Director |
| Mrs. Nilima Goenka | Whole Time Director |
| Mr. Ramsanatan Banerjee | Whole Time Director |
| Mr. Binay Kumar Agarwal | Independent Director |
| Ms. Divyaa Newatia | Independent Director |
| Mr. Girdhari Lal Goenka | Independent Director |
FAQ
What is the intrinsic value of Hindcon Chemicals Ltd?
Hindcon Chemicals Ltd's intrinsic value (as of 05 January 2026) is ₹22.77 which is 16.29% lower the current market price of ₹27.20, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹139 Cr. market cap, FY2025-2026 high/low of ₹45.9/26.1, reserves of ₹48.38 Cr, and liabilities of ₹72.38 Cr.
What is the Market Cap of Hindcon Chemicals Ltd?
The Market Cap of Hindcon Chemicals Ltd is 139 Cr..
What is the current Stock Price of Hindcon Chemicals Ltd as on 05 January 2026?
The current stock price of Hindcon Chemicals Ltd as on 05 January 2026 is ₹27.2.
What is the High / Low of Hindcon Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Hindcon Chemicals Ltd stocks is ₹45.9/26.1.
What is the Stock P/E of Hindcon Chemicals Ltd?
The Stock P/E of Hindcon Chemicals Ltd is 34.9.
What is the Book Value of Hindcon Chemicals Ltd?
The Book Value of Hindcon Chemicals Ltd is 11.0.
What is the Dividend Yield of Hindcon Chemicals Ltd?
The Dividend Yield of Hindcon Chemicals Ltd is 0.00 %.
What is the ROCE of Hindcon Chemicals Ltd?
The ROCE of Hindcon Chemicals Ltd is 9.97 %.
What is the ROE of Hindcon Chemicals Ltd?
The ROE of Hindcon Chemicals Ltd is 7.27 %.
What is the Face Value of Hindcon Chemicals Ltd?
The Face Value of Hindcon Chemicals Ltd is 2.00.